BIO-FLURAZEPAM 30 MG
FLURAZEPAM HYDROCHLORIDE : 30 MG · DIN 02248127 · BIOMED PHARMA
Health Canada status: CANCELLED POST MARKET
What is BIO-FLURAZEPAM?
BIO-FLURAZEPAM 30 MG contains FLURAZEPAM HYDROCHLORIDE : 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02248127, held by BIOMED PHARMA, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 19-Jul-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02248127 |
|---|---|
| Brand name | BIO-FLURAZEPAM |
| Generic / active ingredient | FLURAZEPAM HYDROCHLORIDE : 30 MG |
| Manufacturer | BIOMED PHARMA |
| Strength | 30 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05CD01 FLURAZEPAM |
| AHFS class | 28:24.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 19-Jul-2022 |
| Original market date | 2004-04-23 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05CD01 FLURAZEPAM. 2 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLURAZEPAM | 15 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00521698 |
| FLURAZEPAM | 30 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00521701 |
| BIO-FLURAZEPAM | 15 MG | CAPSULE | BIOMED PHARMA | CANCELLED POST MARKET | DIN 02248126 |
| DALMANE | 15 MG | CAPSULE | VALEANT CANADA LP / VALEANT CANADA S.E.C. | CANCELLED POST MARKET | DIN 00012696 |
| DALMANE | 30 MG | CAPSULE | VALEANT CANADA LP / VALEANT CANADA S.E.C. | CANCELLED POST MARKET | DIN 00012718 |
| FLURAZEPAM 15 | 15 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00578479 |
| FLURAZEPAM 15MG CAPSULE | 15 MG | CAPSULE | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232656 |
| FLURAZEPAM 30 | 30 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00578487 |
| FLURAZEPAM 30MG CAPSULE | 30 MG | CAPSULE | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232657 |
| NOVO-FLUPAM CAP 15MG | 15 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00496545 |
Who else supplies FLURAZEPAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLURAZEPAM appears in 3 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.